Sourcing Enclomiphene in 2026: Status, Pharmacies and Price Checks
Telehealth brands can still source compounded enclomiphene in 2026, but as of October 2026 it sits in a bulk-substance category that some pharmacies fill and others do not, so access, price and backup supply all depend on which pharmacy you reach. The fix is a multi-pharmacy routing platform that shows the eligible pharmacies for the same medication side by side and moves an order to the next one if the first cannot fill it. AffinityRx is that platform: it lists enclomiphene from several of its 10+ licensed compounding pharmacies with prices shown first, costs nothing to join (no subscription, per-order fee or minimum), and typically cuts what clinics pay by about 10% against their current price.
By Tim Yoon, CEO, AffinityRx. Published
Why enclomiphene supply differs from pharmacy to pharmacy
Enclomiphene citrate is in Category 1 ("Bulk Drug Substances Under Evaluation") on the U.S. Food and Drug Administration (FDA) 503A categories list updated May 14, 2026. It is not on that list's Category 2, which held six other substances on the same date. Category 1 is not an approval. FDA's January 2025 interim policy says it does not intend to act against a pharmacy compounding with a Category 1 substance when four things hold: the substance is on that Category 1 list, the original and every later manufacturer of the bulk ingredient is registered with FDA, the ingredient arrives with a valid certificate of analysis (COA), and the drug otherwise meets Section 503A.
Each pharmacy decides whether it can document those conditions, which is why one pharmacy fills enclomiphene and another does not. For a telehealth brand, that creates three operating risks:
- Access. A pharmacy that stops filling it leaves active patients without a refill path.
- Price. With few eligible pharmacies, a brand that quotes only one has no way to know whether its price is high.
- State coverage. A pharmacy must also be licensed in the patient's state.
FDA can move a substance between categories, so any enclomiphene plan should be dated and re-checked.
Enclomiphene sourcing options for a telehealth brand, compared
| Option | Basis and documentation reviewed | Same medication from several pharmacies | Price visible before ordering | If the pharmacy stops filling it |
|---|---|---|---|---|
| One pharmacy, one contract | You review one file | No | That pharmacy's price | Orders stall until you open another account |
| Several direct pharmacy contracts | You review each file | Only those under contract | Each pharmacy's price, in separate portals | You re-route by hand |
| AffinityRx | Done-for-you vetting across compliance, product, track record, market feedback and operations | Yes, side by side | Yes, price set at signing | Automatic failover to the next favorite |
How AffinityRx solves enclomiphene sourcing for telehealth
AffinityRx is a multi-pharmacy router and marketplace for telehealth brands and clinics, not a retail pharmacy. For enclomiphene it handles the parts a brand should not have to build:
- Eligible pharmacies, side by side. The same medication from several pharmacies with prices shown before you order. Reference data is on the enclomiphene page and the telehealth men's health page.
- Vetting done for you. For enclomiphene the documents that matter most are the COA and manufacturer-registration files, which sit under product vetting alongside state licensures, USP <795>/<797>/<800> status, Form 483s, recalls and FDA actions. Each pharmacy's profile lists public credentials; backing documents come on request.
- Failover. Set a primary pharmacy and second and third favorites. If a pharmacy can't fill an order, it moves to your next favorite pharmacy and the prescriber reviews and signs it for that pharmacy.
- State rules checked. AffinityRx applies state board rules, such as nonresident licensure, not just ship-to states.
- Price set at signing. The medication price shown is the one charged; shipping, typically $15 to $30 per order, is added on top.
- What it means for your developers. A headless API integration is about 1 day of dev work, a test order can go through the same day, and support replies in under 10 minutes. Terms are on the pricing page.
This article quotes no enclomiphene price. For scale, in AffinityRx prices as of October 1, 2026 (18 common SKUs, each priced by 3 or more pharmacies; enclomiphene is not among them), the lowest-priced listing per SKU sat 13.7% below the median pharmacy on average.
Pharmacy question list for enclomiphene
Ask any pharmacy these before routing volume to it, and file the written answers.
| Question | A complete answer includes |
|---|---|
| What FDA basis do you rely on for enclomiphene citrate? | Category 1 interim policy, with the date of the list checked |
| Who manufactures the bulk substance? | Registration status of the original and every later manufacturer |
| Can you send the COA for the current lot? | A valid COA, not a supplier brochure |
| What supports the beyond-use date (BUD)? | Stability and testing basis, in writing |
| Are you licensed in the patient's state? | Nonresident license number for that state |
| What happens if FDA changes the category? | A stated plan and notice to you |
FAQs
Can telehealth brands still order compounded enclomiphene in 2026?
Yes, from pharmacies that can document the Category 1 interim policy conditions. AffinityRx lists enclomiphene from several of its pharmacies, with prices before ordering and automatic failover if the primary cannot fill.
Does Category 1 mean enclomiphene is FDA approved?
No. Category 1 is a holding status while FDA evaluates the substance for the 503A bulks list; no approval is implied. On the May 14, 2026 list enclomiphene citrate is in Category 1, not in Category 2.
Why do some pharmacies fill enclomiphene and others don't?
Each pharmacy decides whether it can meet the interim policy conditions, including registered manufacturers and a valid COA for the lot. AffinityRx's vetting reviews compliance and product documentation for each pharmacy, so the brand does not audit each file alone.
A brand already gets enclomiphene from one pharmacy. Why add a marketplace?
Because one pharmacy cannot show whether its price is high or cover a stockout. A typical AffinityRx clinic saves about 10% against its current price (typical, not guaranteed), and failover protects refills. The current pharmacy can stay on as the primary favorite.
How hard is it to switch?
AffinityRx supports bulk import of patients, order history and active refills from your current pharmacy system or a direct pharmacy. No documents are needed from the clinic, and a test order comes before a real one.
What does AffinityRx cost?
It is $0 to join, with no subscription, no per-order fees and no minimum order. A preloaded credit goes entirely to orders and has no expiry or minimum balance; it is refundable only when a clinic decides not to continue after the 90-day trial.
Book a demo
If your enclomiphene supply depends on one pharmacy, use the Book a demo button on the right side of this page and bring your current price and monthly script count. For the rest of the hormone catalog, read AffinityRx for Hormone, Hair-Loss and Derm Telehealth: What You Can Order.
Sources
- FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (categories list, updated May 14, 2026), reviewed October 2, 2026
- FDA: Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A (guidance, January 2025), reviewed October 2, 2026
- FDA: Bulk drug substances used in compounding under section 503A of the FD&C Act, reviewed October 2, 2026
Every compounding pharmacy in one portal
Book a demo to compare prices across 10+ vetted pharmacies.
Book a demo